These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 31921137)

  • 1. Wnt Signaling and Its Significance Within the Tumor Microenvironment: Novel Therapeutic Insights.
    Patel S; Alam A; Pant R; Chattopadhyay S
    Front Immunol; 2019; 10():2872. PubMed ID: 31921137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WNT Signaling in Tumors: The Way to Evade Drugs and Immunity.
    Martin-Orozco E; Sanchez-Fernandez A; Ortiz-Parra I; Ayala-San Nicolas M
    Front Immunol; 2019; 10():2854. PubMed ID: 31921125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt signaling pathway in cancer immunotherapy.
    Zhou Y; Xu J; Luo H; Meng X; Chen M; Zhu D
    Cancer Lett; 2022 Jan; 525():84-96. PubMed ID: 34740608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frizzled7 Promotes Epithelial-to-mesenchymal Transition and Stemness Via Activating Canonical Wnt/β-catenin Pathway in Gastric Cancer.
    Li G; Su Q; Liu H; Wang D; Zhang W; Lu Z; Chen Y; Huang X; Li W; Zhang C; He Y; Fu L; Bi J
    Int J Biol Sci; 2018; 14(3):280-293. PubMed ID: 29559846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WNT signaling and cancer stemness.
    Katoh M; Katoh M
    Essays Biochem; 2022 Sep; 66(4):319-331. PubMed ID: 35837811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review).
    Katoh M
    Int J Oncol; 2017 Nov; 51(5):1357-1369. PubMed ID: 29048660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WNT Signaling in Hematological Malignancies.
    Frenquelli M; Tonon G
    Front Oncol; 2020; 10():615190. PubMed ID: 33409156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WNT/β-Catenin Signaling Pathway Regulating T Cell-Inflammation in the Tumor Microenvironment.
    Li X; Xiang Y; Li F; Yin C; Li B; Ke X
    Front Immunol; 2019; 10():2293. PubMed ID: 31616443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt Signaling Cascade in Dendritic Cells and Regulation of Anti-tumor Immunity.
    Suryawanshi A; Hussein MS; Prasad PD; Manicassamy S
    Front Immunol; 2020; 11():122. PubMed ID: 32132993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emerging role of Wnt5a in the promotion of a pro-inflammatory and immunosuppressive tumor microenvironment.
    Lopez-Bergami P; Barbero G
    Cancer Metastasis Rev; 2020 Sep; 39(3):933-952. PubMed ID: 32435939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The WNT/ROR Pathway in Cancer: From Signaling to Therapeutic Intervention.
    Menck K; Heinrichs S; Baden C; Bleckmann A
    Cells; 2021 Jan; 10(1):. PubMed ID: 33445713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness.
    Liao TT; Yang MH
    Mol Oncol; 2017 Jul; 11(7):792-804. PubMed ID: 28649800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update.
    Clara JA; Monge C; Yang Y; Takebe N
    Nat Rev Clin Oncol; 2020 Apr; 17(4):204-232. PubMed ID: 31792354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusion of macrophages promotes breast cancer cell proliferation, migration and invasion through activating epithelial-mesenchymal transition and Wnt/β-catenin signaling pathway.
    Zhang LN; Huang YH; Zhao L
    Arch Biochem Biophys; 2019 Nov; 676():108137. PubMed ID: 31605677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Encapsulated human mesenchymal stem cells (eMSCs) as a novel anti-cancer agent targeting breast cancer stem cells: Development of 3D primed therapeutic MSCs.
    Mandal S; Arfuso F; Sethi G; Dharmarajan A; Warrier S
    Int J Biochem Cell Biol; 2019 May; 110():59-69. PubMed ID: 30735730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms promoting physiological cells progression into tumorigenesis.
    Korbut E; Ptak-Belowska A; Brzozowski T
    J Physiol Pharmacol; 2012 Dec; 63(6):565-70. PubMed ID: 23388471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functions of Exosomes in the Triangular Relationship between the Tumor, Inflammation, and Immunity in the Tumor Microenvironment.
    Wang T; Nasser MI; Shen J; Qu S; He Q; Zhao M
    J Immunol Res; 2019; 2019():4197829. PubMed ID: 31467934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WNT signaling pathway and stem cell signaling network.
    Katoh M; Katoh M
    Clin Cancer Res; 2007 Jul; 13(14):4042-5. PubMed ID: 17634527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abi1 loss drives prostate tumorigenesis through activation of EMT and non-canonical WNT signaling.
    Nath D; Li X; Mondragon C; Post D; Chen M; White JR; Hryniewicz-Jankowska A; Caza T; Kuznetsov VA; Hehnly H; Jamaspishvili T; Berman DM; Zhang F; Kung SHY; Fazli L; Gleave ME; Bratslavsky G; Pandolfi PP; Kotula L
    Cell Commun Signal; 2019 Sep; 17(1):120. PubMed ID: 31530281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.